Vanguard Group Inc Artivion, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Artivion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,796,635 shares of AORT stock, worth $118 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,796,635
              Previous 2,782,007
              
        
           0.53%
        
      
          
        Holding current value
$118 Million
            Previous $68.4 Million
            
        
           27.19%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  17 transactions
	
  Others Institutions Holding AORT
# of Institutions
201Shares Held
40.1MCall Options Held
19.2KPut Options Held
0- 
    
      Black Rock Inc. New York, NY6.64MShares$281 Million0.0% of portfolio
- 
    
      Macquarie Group LTD Australia, C32.96MShares$125 Million0.12% of portfolio
- 
    
      Perceptive Advisors LLC New York, NY2.79MShares$118 Million3.82% of portfolio
- 
    
      Morgan Stanley New York, NY2.32MShares$98.1 Million0.0% of portfolio
- 
    
      Juniper Investment Company, LLC New York, NY2.09MShares$88.6 Million27.62% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.71B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...